Angle Share News (AGL)

Angle expects 2023 growth to fall short of market expectations

(Alliance News) - Angle PLC on Thursday reported that it expects "growth" in 2023, albeit significantly lower than market estimates, as it anticipates its operating loss to widen.

TRADING UPDATES: Smithson assets grow; FireAngel delivers milestone

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

IN BRIEF: Angle presents positive study results for Parasortix

Angle PLC - Surrey, England-based medical diagnostics company - Says proof of concept study shows that both circulating tumour cells and cell-free circulating tumour DNA can be analysed from a single blood sample. "The results show that removal of plasma from blood samples for circulating tumour DNA analysis does not impact on the number or quality of circulating tumour cells which can be successfully isolated from the same sample using the Parsortix system," it explains.

TRADING UPDATES: essensys loss widens; Carclo demand strong

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

TRADING UPDATES: Angus Energy exceeds monthly production targets

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

LONDON BROKER RATINGS: Berenberg cuts Anglo American and Gem Diamonds

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

EARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Harmony Energy plans raise; Kavango sets drill target

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days

Angle notes Parsortix success in pelvic mass pilot study

(Alliance News) - Angle PLC on Monday noted the publication of results from a clinical study undertaken with Wilmot Cancer Institute, at the University of Rochester, in New York.

TRADING UPDATES: Angle hails study find; Eqtec buys plant in France

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Director dealings: Angle CEO, finance chief join capital raise

(Sharecast News) - Liquid biopsy specialist Angle had two entries on the list of director buys on Tuesday, after its chief executive and chief financial officers invested in shares.

LONDON MARKET CLOSE: Stocks higher as US rate hikes fears calm

(Alliance News) - Stocks in London ended the week in the green after positive retail sales data from the US, easing fears over future US interest rate hikes.

IN BRIEF: Angle raises GBP20 million to progress Parsortix

Angle PLC - Surrey, England-based medical diagnostics company - Raises GBP20.1 million via share placing, marginally above the GBP20.0 million it aimed for.

AIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.